| 词条 | Rous sarcoma virus |
| 释义 |
| name = Rous sarcoma virus | virus_group = vi | ordo = Ortervirales | familia = Retroviridae | subfamilia = Orthoretrovirinae | genus = Alpharetrovirus | species = Rous sarcoma virus }} Rous sarcoma virus (RSV) ({{IPAc-en|r|aʊ|s}}) is a retrovirus and is the first oncovirus to have been described: it causes sarcoma in chickens. As with all retroviruses, it reverse transcribes its RNA genome into cDNA before integration into the host DNA. HistoryRSV was discovered in 1911 by Peyton Rous, working at Rockefeller University in New York City, by injecting cell free extract of chicken tumour into healthy Plymouth Rock chickens. The extract was found to induce oncogenesis. The tumour was found to be composed of connective tissue (a sarcoma).[1][2] Thus, RSV became known as the first oncogenic retrovirus that could be used to study the development of cancer molecularly.[3] In 1958, Harry Rubin and Howard Temin developed an assay where chicken embryo fibroblasts could be altered morphologically by RSV infection. Two years later Temin concluded that the transformed morphology of the cells was controlled by a genetic property of RSV. At that time it was unknown, but later the src gene was identified as responsible for morphological transformation in healthy cells. During the 1960s, two findings emerged: replication-competent isolated viruses were related to RSV, but were non-transforming, and an isolated replication-defective strain of RSV was transformation-competent. These two findings gave rise to the notion that viral replication and malignant transformation are separate processes in RSV.[4] Rous was awarded the Nobel Prize in Physiology or Medicine for the significance of his discovery in 1966.[5] Subsequently after other oncogenic human viruses, such as Epstein-Barr virus, were discovered. Furthermore, oncogenes were found initially in retroviruses and then in cells.[3] Structure and genome{{Infobox rfam| Name = Retroviral 3'UTR stability element | image = RF01417.png | width = 200 | caption = Predicted secondary structure of the Rous sarcoma virus retroviral 3'UTR stability element | Symbol = | AltSymbols = | Rfam = RF01417 | miRBase = | miRBase_family = | RNA_type = Cis-reg | Tax_domain = | CAS_number = | EntrezGene = | HGNCid = | OMIM = | PDB = | RefSeq = | Chromosome = | Arm = | Band = | LocusSupplementaryData = }} RSV is a class VI enveloped virus with a positive sense RNA genome having a DNA intermediate. RSV has four genes:
The RSV genome has terminal repeats enabling its integration into the host genome and also overexpression of RSV genes. Src gene{{main|v-Src}}The src gene is oncogenic as it triggers uncontrolled growth in abnormal host cells. It was the first retroviral oncogene to be discovered.[6] It is an acquired gene, found to be present throughout the animal kingdom with high levels of conservation between species. The src gene was taken up by RSV and incorporated into its genome conferring it with the advantage of being able to stimulate uncontrolled mitosis of host cells, providing abundant cells for fresh infection. The src gene is not essential for RSV proliferation but it greatly increases virulence when present. Src is a tyrosine kinase involved in regulation of cell growth and differentiation. It has an SH2 and SH3 domain, which are responsible for its activation and deactivation.[4] RNA secondary structureThe RNA genome of RSV contains an extremely long 3' UTR that ranges between 5–7 kb in length which would usually direct it toward nonsense mediated decay (NMD) within the eukaryotic host cell. A conserved secondary structure element has been identified within the 3'UTR and is known as the Rous Sarcoma Virus Stability Element (RSE).[7] This element has been shown to prevent the degradation of the unspliced viral RNA.[7] The RSE element was first identified in the genome of the Rous Sarcoma Virus but appears to be widely conserved across the avian retrovirus family. The RSE element is ~300 bp in length and located downstream of the gag natural translational termination codon. The secondary structure of the RSE element has been determined by RNAse digestion and SHAPE chemistry analysis.[8] Other elements that have been identified in RSV include a primer binding site.[9] Gag proteinGag proteins are necessary for virion assembly and mature virus infection of the host cell. The gag protein (Pr76) for RSV contains 701 amino acids. It is cleaved by virus encoded protease, releasing products found in the infectious virion. These cleaved products include the matrix (MA), capsid (CA), and nucleocapsid (NC), which are able to enter other pathways to infect new cells.[10][11] RSV envelopeRSV has an envelope which has one glycoprotein: env. Env is made up of gp85 and gp37, which are glycoproteins that assemble into oligomers. The function of env is to bind RSV to the host cell receptor and induce fusion with the target cell in a pH independent manner. The envelope is acquired during exocytosis. The virus buds or pushes on the plasma membrane, which allows it to leave the cell with a new outer membrane from the host cell.[10][12] Replication cycleCell entryThere are two ways viruses can enter the host cell: cell receptor endocytosis or fusion. Endocytosis is the process where the virus binds a receptor on the target cell membrane, and the virus is taken into or endocytosed into the cell. Endocytosis can either be pH independent or pH dependent. Fusion occurs when the virus fuses together with the target cell membrane and releases its genome into the cell. RSV enters the host cell through fusion of the host cell membrane.[13] TranscriptionIn order for the RSV genome transcription to occur, a primer is required. 4S RNA is the primer for RSV and 70S RNA serves as the template for DNA synthesis. Reverse transcriptase, an RNA-dependent DNA polymerase, transcribes viral RNA into the full length DNA complement.[14] References1. ^{{cite journal | author = Rous P | title = A Transmissible Avian Neoplasm (Sarcoma of the Common Fowl) | journal = J. Exp. Med. | volume = 12 | issue = 5 | pages = 696–705 |date=September 1910 | pmid = 19867354 | pmc = 2124810 | doi = 10.1084/jem.12.5.696| url = }} 2. ^{{cite journal | author = Rous P | title = A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells | journal = J. Exp. Med. | volume = 13 | issue = 4 | pages = 397–411 |date=April 1911 | pmid = 19867421 | pmc = 2124874 | doi =10.1084/jem.13.4.397 }} 3. ^1 {{cite journal |vauthors=Weiss RA, Vogt PK | title = 100 years of Rous sarcoma virus | journal = J. Exp. Med. | volume = 208 | issue = 12 | pages = 2351–5 |date=November 2011 | pmid = 22110182 | pmc = 3256973 | doi = 10.1084/jem.20112160 }} 4. ^1 {{cite journal | author = Martin GS | title = The hunting of the Src | journal = Nat. Rev. Mol. Cell Biol. | volume = 2 | issue = 6 | pages = 467–75 |date=June 2001 | pmid = 11389470 | doi = 10.1038/35073094 }} 5. ^Nobelprize.org [https://www.nobelprize.org/nobel_prizes/medicine/laureates/1966/rous.html The Nobel Prize in Physiology or Medicine 1966: Peyton Rous], retrieved 1 Jul 2012 6. ^{{cite journal | author = Vogt PK | title = Retroviral oncogenes: a historical primer | journal = Nat. Rev. Cancer | volume = 12 | issue = 9 | pages = 639–48 |date=September 2012 | pmid = 22898541 | pmc = 3428493 | doi = 10.1038/nrc3320 }} 7. ^1 {{cite journal |vauthors=Weil JE, Beemon KL | title = A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus | journal = RNA | volume = 12 | issue = 1 | pages = 102–10 |date=January 2006 | pmid = 16301601 | pmc = 1370890 | doi = 10.1261/rna.2129806 }} 8. ^{{cite journal |vauthors=Weil JE, Hadjithomas M, Beemon KL | title = Structural characterization of the Rous sarcoma virus RNA stability element | journal = J. Virol. | volume = 83 | issue = 5 | pages = 2119–29 |date=March 2009 | pmid = 19091866 | pmc = 2643715 | doi = 10.1128/JVI.02113-08 }} 9. ^{{cite journal |vauthors=Johnson M, Morris S, Chen A, Stavnezer E, Leis J | title = Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome | journal = BMC Biol. | volume = 2| pages = 8 | year = 2004 | pmid = 15153244 | pmc = 428589 | doi = 10.1186/1741-7007-2-8 }} 10. ^1 {{cite journal |vauthors=Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J | title = An assembly domain of the Rous sarcoma virus Gag protein required late in budding | journal = J. Virol. | volume = 68 | issue = 10 | pages = 6605–18 |date=October 1994 | pmid = 8083996 | pmc = 237081 | doi = }} 11. ^{{cite journal |vauthors=Nadaraia-Hoke S, Bann DV, Lochmann TL, Gudleski-O'Regan N, Parent LJ | title = Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein | journal = J. Virol. | volume = 87 | issue = 6 | pages = 3609–15 |date=March 2013 | pmid = 23325682 | doi = 10.1128/JVI.03059-12 | pmc = 3592118 }} 12. ^{{cite journal |vauthors=Einfeld D, Hunter E | title = Oligomeric structure of a prototype retrovirus glycoprotein | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 85 | issue = 22 | pages = 8688–92 |date=November 1988 | pmid = 2847170 | pmc = 282525 | doi =10.1073/pnas.85.22.8688 | bibcode = 1988PNAS...85.8688E }} 13. ^{{cite journal |vauthors=Gilbert JM, Mason D, White JM | title = Fusion of Rous sarcoma virus with host cells does not require exposure to low pH | journal = J. Virol. | volume = 64 | issue = 10 | pages = 5106–13 |date=October 1990 | pmid = 2168989 | pmc = 248002 | doi = }} 14. ^{{cite journal | vauthors = Dahlberg JE, Sawyer RC, Taylor JM, Faras AJ, Levinson WE, Goodman HM, Bishop JM | title = Transcription of DNA from the 70S RNA of Rous sarcoma virus. I. Identification of a specific 4S RNA which serves as primer | journal = J. Virol. | volume = 13 | issue = 5 | pages = 1126–33 | date = May 1974 | pmid = 4132919 | pmc = 355423 }} External links
2 : Alpharetroviruses|Infectious causes of cancer |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。